PNPLA3 and metabolic dysfunction-associated steatohepatitis: This allowed establishing a panel combining adiponectin and nine serum lipids (mainly TG, PC, and SM), reaching an AUROC value of ~0.80 and an overall accuracy of 74% in distinguishing NAFL from NASH in all patients, regardless of PNPLA3 genotype.